Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 66

Sort by

Sort Order Select

Journal Articles

Tumor mutational burden as a novel biomarker of resistance to CD19 CAR-T cell therapy in large B-cell lymphoma

Blood (2025) 146 (Supplement 1): 565.

https://doi.org/10.1182/blood-2025-565

Published: 2025

Journal Articles

Respiratory viral infections are a significant cause of morbidity during long-term follow-up after CAR T cell therapy: Analysis of 445 episodes

Blood (2025) 146 (Supplement 1): 4498.

https://doi.org/10.1182/blood-2025-4498

Published: 2025

Journal Articles

Patterns of patient referral for CAR-T cell therapy: Increasing access and changing utilization trends at a german tertiary care hospital from 2018 to 2024

Christian Rausch, Adrian Gottschlich, Giulia Magno, Stefanie Griesshammer, Tobias Tix, Michael Von Bergwelt, Kai Rejeski, Marion Subklewe, Veit Buecklein

Blood (2025) 146 (Supplement 1): 4418.

https://doi.org/10.1182/blood-2025-4418

Published: 2025

Journal Articles

Hematotoxicity and immune deficits with bispecific antibodies: A systematic review and meta-analysis in lymphoma and multiple myeloma

Tobias Tix, Mohammad Alhomoud, Jaromir Tomasik, Gloria Iacoboni, Edward Cliff, Doris Hansen, Saad Usmani, Gilles Salles, Marion Subklewe, Michael Von Bergwelt, Samuel Yamshon, Miguel-Angel Perales, Roni Shouval, David Cordas Dos Santos, Kai Rejeski

Blood (2025) 146 (Supplement 1): 8135.

https://doi.org/10.1182/blood-2025-8135

Published: 2025

Journal Articles

Early intervention for cytokine release syndrome after chimeric antigen receptor T-cell therapy is associated with an increased risk of cytopenias and infections in patients with large B-cell lymphoma

Blood (2025) 146 (Supplement 1): 1944.

https://doi.org/10.1182/blood-2025-1944

Published: 2025

Journal Articles

Central nervous system relapse is uncommon after chimeric antigen receptor T-cell therapy for relapsed/refractory large B-cell lymphoma

Blood (2025) 146 (Supplement 1): 5497.

https://doi.org/10.1182/blood-2025-5497

Published: 2025

Journal Articles

Long-term cardiovascular outcomes in patients with lymphoma who had early post-CAR-T cardiovascular events: A multi-center, international study

Blood (2025) 146 (Supplement 1): 3723.

https://doi.org/10.1182/blood-2025-3723

Published: 2025

Journal Articles

First-line salvage therapies in relapsed/refractory large B-cell lymphoma after second- or third-line CD19-directed CAR T-cell therapy

Blood (2025) 146 (Supplement 1): 3711.

https://doi.org/10.1182/blood-2025-3711

Published: 2025

Journal Articles

Neuroinflammation detected by TSPO-PET precedes dopaminergic neuronal loss in mnt following BCMA-directed CAR-T therapy: Longitudinal multimodal neuroimaging and biomarker insights

Veit Buecklein, Katharina Mueller, Florian Schoeberl, Adrian Gottschlich, Giulia Rappa, Gerulf Haenel, Tobias Tix, Steffen Tiedt, Sophia Stoecklein, Johannes Gnoerich, Nathalie Albert, Matthias Brendel, Michael Von Bergwelt, Kai Rejeski, Marion Subklewe, Louisa von Baumgarten

Blood (2025) 146 (Supplement 1): 4172.

https://doi.org/10.1182/blood-2025-4172

Published: 2025

Journal Articles

Adipose tissue-associated lipid serum signatures modulate efficacy and toxicity of CAR-T cell therapy in lymphoid malignancies

David Cordas Dos Santos, Hannah Thurisch, Jingke Tu, Daniel Heilpern-Mallory, Amar Hadzic, Martin Kirmaier, Werner Schmitz, Martin Vaeth, Sabine Oganesian, Adriano Carboniero, Ludovica Vona, Viktoria Blumenberg, Veit Buecklein, Michael Von Bergwelt, Kai Rejeski, Marion Subklewe, Sebastian Theurich

Blood (2025) 146 (Supplement 1): 5887.

https://doi.org/10.1182/blood-2025-5887

Published: 2025

Journal Articles

Pre-existing clonal hematopoiesis in CAR-T recipients is not associated with increased immunotoxicity and inflammatory serum signatures

Giulia Rappa, Frank Ziemann, Kieron White, Amelie Muth, Cristina Zucchinetti, Maja Rothenberg-Thurley, Tobias Tix, Agnese Petrera, Bianka Ksienzyk, Charlotte Bentenrieder, Fabian Müller, Veit Buecklein, Kai Rejeski, Marion Subklewe

Blood (2025) 146 (Supplement 1): 2366.

https://doi.org/10.1182/blood-2025-2366

Published: 2025

Journal Articles

Respiratory syncytial virus (RSV) infection after CAR T-cell therapy

Blood (2025) 146 (Supplement 1): 1079.

https://doi.org/10.1182/blood-2025-1079

Published: 2025

Journal Articles

Safety and efficacy of brexucabtagene autoleucel in elderly patients with relapsed or refractory Mantle Cell Lymphoma: A retrospective, multicenter, international study

Blood (2025) 146 (Supplement 1): 2710.

https://doi.org/10.1182/blood-2025-2710

Published: 2025

Journal Articles

Image-based classification of lymphocyte subsets from routine blood smears reveals distinct immune dynamics after CAR-T infusion

Sean Paulsen, Greg Goldgof, Chad Vanderbilt, Cesar Colorado-Jimenez, Dylan Webb, Sapir Israeli, Anthony Cardillo, Ali Kamali, Maly Fenelus, Samuel McCash, Teng Fei, Linlin Wang, Lauren McVoy, Kai Rejeski, Roni Shouval, Ahmet Dogan

Blood (2025) 146 (Supplement 1): 4354.

https://doi.org/10.1182/blood-2025-4354

Published: 2025

Journal Articles

Pre-treatment vaccine seroprotection is markedly lower in BCMA-CAR vs CD19-CAR recipients with limited post-therapy modulation

Giulia Magno, Elif Apak, Savanna Süß, Giulia Rappa, Patricia M. Späth, Sophia Stock, Alessandra Holzem, Wajma Shahbaz, Tobias Tix, Bernhard Ismann, Judith S. Hecker, Florian Bassermann, Sebastian Theurich, Michael Von Bergwelt, Kai Rejeski, Oliver T. Keppler, Marion Subklewe, Veit Buecklein

Blood (2025) 146 (Supplement 1): 6355.

https://doi.org/10.1182/blood-2025-6355

Published: 2025

Journal Articles

Beyond ECOG: Assessment of physical function enhances risk stratification prior to CAR-T cell therapy

Alessandra Holzem, Michael Ingrisch, Anna Magee, Veronika Kezzo, Tobias Tix, Sophia Stock, Giulia Magno, Wajma Shahbaz, Michaela Braxenthaler, Michael Von Bergwelt, Wolfgang Kunz, Veit Buecklein, Sebastian Theurich, Marion Subklewe, Kai Rejeski

Blood (2025) 146 (Supplement 1): 6331.

https://doi.org/10.1182/blood-2025-6331

Published: 2025

Journal Articles

Impact of holding therapy prior to apheresis on outcomes following CD19 CAR-T cell therapy in large B-cell lymphoma

Blood (2025) 146 (Supplement 1): 6328.

https://doi.org/10.1182/blood-2025-6328

Published: 2025

Journal Articles

Large B-cell lymphoma imprints a dysfunctional immune phenotype that persists years after treatment

Blood (2025) 146 (11): 1300–1313.

https://doi.org/10.1182/blood.2024027877

Published: 2025

Includes: Supplemental data

Journal Articles

T-ICAHT: grading and prognostic impact of thrombocytopenia after CAR T-cell therapy

Blood (2025) 146 (7): 834–846.

https://doi.org/10.1182/blood.2025028833

Published: 2025

Includes: Supplemental data

Journal Articles

Development of ALL-Hematotox: predicting post-CAR T-cell hematotoxicity in B-cell acute lymphoblastic leukemia

Monica S. Nair, Sara K. Silbert, Kai Rejeski, Karilynn A. Wilson, Adam J. Lamble, Yannis Valtis, Bonnie Yates, Alexa Morales Arana, Roni Shouval, Kevin Curran, Rebecca A. Gardner, Haneen Shalabi, Colleen Annesley, Jae H. Park, Marion Subklewe, Nirali N. Shah

Blood (2025) 145 (11): 1136–1148.

https://doi.org/10.1182/blood.2024025910

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Tumor mutational burden as a novel biomarker of resistance to CD19 CAR-T cell therapy in large B-cell lymphoma

Respiratory viral infections are a significant cause of morbidity during long-term follow-up after CAR T cell therapy: Analysis of 445 episodes

Patterns of patient referral for CAR-T cell therapy: Increasing access and changing utilization trends at a german tertiary care hospital from 2018 to 2024

Hematotoxicity and immune deficits with bispecific antibodies: A systematic review and meta-analysis in lymphoma and multiple myeloma

Early intervention for cytokine release syndrome after chimeric antigen receptor T-cell therapy is associated with an increased risk of cytopenias and infections in patients with large B-cell lymphoma

Central nervous system relapse is uncommon after chimeric antigen receptor T-cell therapy for relapsed/refractory large B-cell lymphoma

Long-term cardiovascular outcomes in patients with lymphoma who had early post-CAR-T cardiovascular events: A multi-center, international study

First-line salvage therapies in relapsed/refractory large B-cell lymphoma after second- or third-line CD19-directed CAR T-cell therapy

Neuroinflammation detected by TSPO-PET precedes dopaminergic neuronal loss in mnt following BCMA-directed CAR-T therapy: Longitudinal multimodal neuroimaging and biomarker insights

Adipose tissue-associated lipid serum signatures modulate efficacy and toxicity of CAR-T cell therapy in lymphoid malignancies

Pre-existing clonal hematopoiesis in CAR-T recipients is not associated with increased immunotoxicity and inflammatory serum signatures

Respiratory syncytial virus (RSV) infection after CAR T-cell therapy

Safety and efficacy of brexucabtagene autoleucel in elderly patients with relapsed or refractory Mantle Cell Lymphoma: A retrospective, multicenter, international study

Image-based classification of lymphocyte subsets from routine blood smears reveals distinct immune dynamics after CAR-T infusion

Pre-treatment vaccine seroprotection is markedly lower in BCMA-CAR vs CD19-CAR recipients with limited post-therapy modulation

Beyond ECOG: Assessment of physical function enhances risk stratification prior to CAR-T cell therapy

Impact of holding therapy prior to apheresis on outcomes following CD19 CAR-T cell therapy in large B-cell lymphoma

Large B-cell lymphoma imprints a dysfunctional immune phenotype that persists years after treatment

T-ICAHT: grading and prognostic impact of thrombocytopenia after CAR T-cell therapy

Development of ALL-Hematotox: predicting post-CAR T-cell hematotoxicity in B-cell acute lymphoblastic leukemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only